LCI
Lannett Company, Inc.
NYSEHealthcareDrug Manufacturers - Specialty & GenericUS
Company Profile
CEO
Timothy C. Crew
IPO Date
2013-12-13
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
US
Lannett Company, Inc.
CEO
Timothy C. Crew
IPO Date
2013-12-13
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
US
| 15,000 |
| $0.48 |
| 14 Nov 2022 | LEPORE PATRICK G | director | P-Purchase | Acquired | 100,000 | $0.49 |
| 15 Sept 2022 | Rewolinski Melissa | director | P-Purchase | Acquired | 31,159 | $0.49 |
| 8 Sept 2022 | Abt John | Chief Quality and Operations | F-InKind | Disposed | 950 | $0.47 |
| 8 Sept 2022 | KOZLOWSKI JOHN | VP of Finance & CFO | F-InKind | Disposed | 775 | $0.47 |
| 1 Aug 2022 | Abt John | Chief Quality and Operations | F-InKind | Disposed | 3,924 | $0.58 |
| 1 Aug 2022 | Crew Timothy C | Chief Executive Officer | F-InKind | Disposed | 19,368 | $0.58 |
| 1 Aug 2022 | KOZLOWSKI JOHN | VP of Finance & CFO | F-InKind | Disposed | 3,330 | $0.58 |
| 1 Aug 2022 | KOZLOWSKI JOHN | VP of Finance & CFO | F-InKind | Disposed | 8,114 | $0.58 |